Clinical Trials Browser

Phase EARLY_PHASE1 × Paraganglioma × 90 days × Clear all

NCT05636540 2026-02-27

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Phase EARLY_PHASE1 Recruiting

Paraganglioma, Pheochromocytoma